Skip to content

Pilot Study on Deploying Oncology-Specific Telemedicine (TeleOPD) Platform in the North-Eastern States of India

Deploying Oncology Specific Telemedicine (TeleOPD) platform in the North- Eastern states of India a pilot study - TeleOPD

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/02/080742
Enrollment
50
Registered
2025-02-18
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

National Cancer Grid
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years and above. 2. Patients who are willing to provide informed consent for participation in the study. 3. Patients who are able to communicate in the local language (Manipuri), Hindi/English. 4. Patients who are clinically stable and do not require emergency care. 5. Follow-up patients who have been treated at Tata Memorial Hospital (TMH) and are in remission at the last physical follow-up. 6. Patients who have completed treatment and are now on follow-up but have symptoms requiring examination. 7. New patients 8. Patients seeking a second opinion

Exclusion criteria

Exclusion criteria: 1.Patients who are unable to communicate effectively in the local language/Hindi/English. 2.Patients with cognitive impairments that prevent them from understanding and following telemedicine instructions.

Design outcomes

Primary

MeasureTime frame
1.To establish telemedicine consultations for cancer care in rural and remote areas of North East India, utilizing NCG experts. 2.To develop and implement a training program for local healthcare providers on NCG guidelines and the use of the telemedicine platform. 3.To facilitate seamless coordination between primary care providers, local hospitals (spokes), and specialized center Tata Memorial Hospital (the hub) for ongoing patient management and follow-up care of patients with cancerTimepoint: Time point for first objective: 2 months Time point for second objective: 1 month Timepoint for third objective: 08 month

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Manju Sengar

Tata Memorial Hospital

manju.sengar@gmail.com9769690590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026